Tagged anthrax

First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book
Press Release

First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book

 Read More
First Light Diagnostics Receives Additional Funding From the Biomedical Advanced Research and Development Authority (BARDA)
Press Release

First Light Diagnostics Receives Additional Funding From the Biomedical Advanced Research and Development Authority (BARDA)

 For development of the breakthrough MultiPath platform and culture-free, anti-microbial susceptibility tests Read More
Press Release

Hema Diagnostic Systems, L.L.C. Announces the Final Validation Process for a New Rapid Anthrax Ab Test

 Hema Diagnostic Systems (HDS) announces the final validation process of a new Anthrax Toxin rapid test for the detection and differentiation between the Anthrax Protective Antigen (PA) and the Lethal Factor (LF) using whole blood or serum. Read More
Press Release

Hema Diagnostic Systems in Discussions for Equity Investment by Generex Biotechnology Corp.

 HEMA DIAGNOSTIC SYSTEMS announces the execution of a non-binding letter of intent with Generex Biotechnology Corporation. HDS and Generex will work together to bring technologies developed by both companies together by incorporating the new and novel rapid diagnostic test systems for worldwide market expansion. Read More
Press Release

More than 100 Leading Organizations from Around the World to Convene in Washington, DC for Detection Technologies 2009

 Detection & Identification of Pathogens, Biological Threats and Infectious Diseases - Detection Technologies is an internationally recognized event for experts in detection and identification of pathogens, biological threats and infectious diseases Read More